Warning: The NCBI web site requires JavaScript to function. more...
Photodynamic therapy in the therapy for recurrent/persistent nasopharyngeal cancer.
Wildeman MA, Nyst HJ, Karakullukcu B, Tan BI.
Head Neck Oncol. 2009 Dec 17;1:40. Review.
Related citations
Photodynamic therapy for residual or recurrent cancer of the nasopharynx.
Kulapaditharom B, Boonkitticharoen V.
J Med Assoc Thai. 1999 Nov;82(11):1111-7.
Linear accelerator-based stereotactic radiosurgery for limited, locally persistent, and recurrent nasopharyngeal carcinoma: efficacy and complications.
Chua DT, Sham JS, Kwong PW, Hung KN, Leung LH.
Int J Radiat Oncol Biol Phys. 2003 May 1;56(1):177-83.
Long term results of radioactive gold grain implantation for the treatment of persistent and recurrent nasopharyngeal carcinoma.
Kwong DL, Wei WI, Cheng AC, Choy DT, Lo AT, Wu PM, Sham JS.
Cancer. 2001 Mar 15;91(6):1105-13.
Photodynamic therapy for recurrent nasopharyngeal cancer.
Lofgren LA, Hallgren S, Nilsson E, Westerborn A, Nilsson C, Reizenstein J.
Arch Otolaryngol Head Neck Surg. 1995 Sep;121(9):997-1002.
Results and prognostic factors in the retreatment of locally recurrent nasopharyngeal carcinoma.
Hwang JM, Fu KK, Phillips TL.
Int J Radiat Oncol Biol Phys. 1998 Jul 15;41(5):1099-111.
Preliminary results of photodynamic therapy for recurrent nasopharyngeal carcinoma.
Tong MC, van Hasselt CA, Woo JK.
Eur Arch Otorhinolaryngol. 1996;253(3):189-92.
Enhancing the therapeutic responsiveness of photodynamic therapy with the antiangiogenic agents SU5416 and SU6668 in murine nasopharyngeal carcinoma models.
Zhou Q, Olivo M, Lye KY, Moore S, Sharma A, Chowbay B.
Cancer Chemother Pharmacol. 2005 Dec;56(6):569-77. Epub 2005 Jul 7.
In vivo fluence rate measurements during Foscan-mediated photodynamic therapy of persistent and recurrent nasopharyngeal carcinomas using a dedicated light applicator.
van Veen RL, Nyst H, Rai Indrasari S, Adham Yudharto M, Robinson DJ, Tan IB, Meewis C, Peters R, Spaniol S, Stewart FA, Levendag PC, Sterenborg HJ.
J Biomed Opt. 2006 Jul-Aug;11(4):041107.
The efficacy of photodynamic therapy in treatment of recurrent squamous cell and basal cell carcinoma.
Farhadi M, Kamrava SK, Behzadi AH, Rafiezadeh P, Asghari A, Rezvan F, Maleki S.
J Drugs Dermatol. 2010 Feb;9(2):122-6.
Long-term survival of patients treated with photodynamic therapy for carcinoma in situ and early non-small-cell lung carcinoma.
Corti L, Toniolo L, Boso C, Colaut F, Fiore D, Muzzio PC, Koukourakis MI, Mazzarotto R, Pignataro M, Loreggian L, Sotti G.
Lasers Surg Med. 2007 Jun;39(5):394-402.
Photodynamic therapy of lung cancer.
Lam S.
Semin Oncol. 1994 Dec;21(6 Suppl 15):15-9. Review.
Chemoradiotherapy for locally recurrent nasopharyngeal carcinoma: treatment outcome and prognostic factors.
Nakamura T, Kodaira T, Tachibana H, Tomita N, Tomoda T, Nakahara R, Inokuchi H, Mizoguchi N, Takada A, Fuwa N.
Jpn J Clin Oncol. 2008 Dec;38(12):803-9. Epub 2008 Oct 7.
[Repeated radiotherapy in locally recurrent nasopharyngeal cancer].
Lengyel E, Baricza K, Somogyi A, Olajos J, Pápai Z, Gödény M, Németh G, Esik O.
Orv Hetil. 2002 Oct 13;143(41):2343-50. Hungarian.
Stereotactic radiosurgery plus intracavitary irradiation in the salvage of nasopharyngeal carcinoma.
Low JS, Chua ET, Gao F, Wee JT.
Head Neck. 2006 Apr;28(4):321-9.
Adjuvant fractionated high-dose-rate intracavitary brachytherapy after external beam radiotherapy in Tl and T2 nasopharyngeal carcinoma.
Lu JJ, Shakespeare TP, Tan LK, Goh BC, Cooper JS.
Head Neck. 2004 May;26(5):389-95.
Nasopharyngeal carcinoma with orbital involvement.
Lee KY, Seah LL, Tow S, Cullen JF, Fong KS.
Ophthal Plast Reconstr Surg. 2008 May-Jun;24(3):185-9.
Effect of photodynamic therapy on selected laboratory values of patients with nasopharyngeal carcinoma.
Lai JP, Tao ZD, Xiao JY, Zhao SP, Tian YQ.
Ann Otol Rhinol Laryngol. 1997 Aug;106(8):680-2.
Treatment outcome for synchronous locoregional failures of nasopharyngeal carcinoma.
Chua DT, Wei WI, Sham JS, Cheng AC, Au G.
Head Neck. 2003 Jul;25(7):585-94.
Biodistribution and photodynamic therapy with hypericin in a human NPC murine tumor model.
Du HY, Bay BH, Olivo M.
Int J Oncol. 2003 May;22(5):1019-24.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on